@article{cdb87e530c43426aa0e8fb5a00843b6e,
title = "Reply: Chronic Kidney Disease and Antiplatelet Therapy: A Worrying Gap Between Evidence Based Medicine and Clinical Practice",
author = "Usman Baber and Jaya Chandrasekhar and Roxana Mehran",
note = "Funding Information: Please note: The PROMETHEUS study was sponsored and funded by Daiichi- Sankyo and Eli Lilly. Dr. Mehran has received institutional grant support from AstraZeneca, The Medicines Company, Bristol-Myers Squibb/Sanofi, and Eli Lilly/Daiichi-Sankyo; and is a consultant to Abbott Vascular, AstraZeneca, Boston Scientific, Covidien, Janssen Pharmaceuticals, Regado Biosciences, Maya Medical, Merck, and The Medicines Company. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose. ",
year = "2018",
month = feb,
day = "12",
doi = "10.1016/j.jcin.2017.12.009",
language = "English",
volume = "11",
pages = "320--297",
journal = "JACC: Cardiovascular Interventions",
issn = "1936-8798",
publisher = "Elsevier Inc.",
number = "3",
}